Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequences

Gene Therapy volume 6, pages 1360–1367 (1999)Cite this article

Abstract

Replication defective viral vectors provide a potentially useful means of gene transfer to oligodendrocytes and thus for studying the pathogenesis of white matter disease. In this study we have examined the expression pattern of E1/E3 deleted adenoviral vectors expressing the reporter gene LacZ (AdlacZ) as a means of establishing the value of these vectors for gene delivery to oligodendrocytes in adult rat white matter. Our results indicate that although such an approach can be used to induce transgene expression in oligodendrocytes, it is complicated by both immunogenic and cytopathic effects. Thus, in normal animals, injection of ΔE1/E3 adenoviral vectors was associated with a robust immune response that led to a lack of expression by 40 days after injection. In order to overcome this complication, virus was injected into the white matter of immuno-deficient athymic rats. These experiments indi- cated that even in the absence of a T cell response high viral titres of ΔE1/E3 adenoviral vectors had a profound cytopathic effect leading to death of oligodendrocytes and hence demyelination. A similar cytopathic effect was demonstrated using an adenoviral vector expressing the neurocytokine ciliary neurotrophic factor (AdCNTF). As the titre of injected virus was decreased there was a significant decrease in the number of transgene expressing cells. These experiments therefore indicated that in immunodeficient recipients there is a narrow window of virus titre that results in a high rate of infectivity and expression without significant cytopathic consequences. At higher viral titres the cytopathic effects include oligodendrocyte death and demyelination, while at lower titres there is a significant decrease in the efficiency of the number of cells expressing the transgene.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 15
Figure 16
Figure 14

Similar content being viewed by others

References

  1. Yang N-S . Gene transfer into mammalian somatic cells in vivo Crit Rev Biotech 1992 12: 335–356

    Article  CAS  Google Scholar 

  2. Gunzburg WH, Salmons B . Virus vector design in gene therapy Mol Med Today 1995 1: 410–417

    Article  CAS  Google Scholar 

  3. Kozarsky KF, Wilson JM . Gene therapy: adenovirus vectors Current Biol 1993 3: 499–503

    Article  CAS  Google Scholar 

  4. Le Gal La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain Science 1993 259: 988–990

    Article  CAS  Google Scholar 

  5. Akli S et al. Transfer of a foreign gene into the brain using adenovirus vectors Nat Genet 1993 3: 224–228

    Article  CAS  Google Scholar 

  6. Davidson BL et al. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector Nat Genet 1993 3: 219–223

    Article  CAS  Google Scholar 

  7. Hermens WTJMC et al. Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS J Neurosci Meth 1997 71: 85–98

    Article  CAS  Google Scholar 

  8. Hashimoto M et al. A neural cell-type-specific expression system using recombinant adenovirus vectors Hum Gene Ther 1996 7: 149–158

    Article  CAS  Google Scholar 

  9. Byrnes AP, Rusby JE, Wood MJA, Charlton HM . Adenovirus gene transfer causes inflamation in the brain Neurosci 1995 66: 1015–1024

    Article  CAS  Google Scholar 

  10. Byrnes AP, MacLaren RE, Charlton HM . Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination J Neurosci 1996 16: 3045–3055

    Article  CAS  Google Scholar 

  11. Wood MJ et al. Immune responses to adenovirus vectors in the nervous system Trends Neurosci 1996 19: 497–501

    Article  CAS  Google Scholar 

  12. Peltekian E et al. Adenovirus mediated gene transfer to the brain: methodological assessment J Neurosci Meth 1997 71: 77–84

    Article  CAS  Google Scholar 

  13. Hermens WTJMC, Verhaagen J . Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astroglial cells in nude rats Hum Gene Ther 1997 8: 1049–1063

    Article  CAS  Google Scholar 

  14. Louis J-C, Magal E, Takayama S, Varon S . CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death Science 1993 259: 689–692

    Article  CAS  Google Scholar 

  15. Barres BA et al. Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation Mol Cell Neurosci 1996 8: 146–156

    Article  CAS  Google Scholar 

  16. Franklin RJM, Barnett SC . The electron microscopic appearance of the beta-galactosidase reaction product Acta Neuropathol 1991 81: 686–687

    Article  CAS  Google Scholar 

  17. Franklin RJM, Bayley SA, Blakemore WF . Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated spinal cord but not in normal spinal cord Exp Neurol 1996 137: 263–276

    Article  CAS  Google Scholar 

  18. Franklin RJM, Blakemore WF . Requirements for Schwann cell migration within CNS environments: a viewpoint Int J Dev Neurosci 1993 11: 641–649

    Article  CAS  Google Scholar 

  19. Haase G et al. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors Nature Med 1997 3: 429–436

    Article  CAS  Google Scholar 

  20. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A . Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors Nat Genet 1993 3: 229–234

    Article  CAS  Google Scholar 

  21. Haase G et al. Therapeutic benefit of CNTF in progressive motor neuronopathy depends on the route of delivery Ann Neurol 1999 45: 296–304

    Article  CAS  Google Scholar 

  22. Shy ME et al. An adenoviral vector can transfer lacZ expression into Schwann cells in culture and in sciatic nerve Ann Neurol 1995 38: 429–436

    Article  CAS  Google Scholar 

  23. Sorensen J et al. Gene transfer to Schwann cells after peripheral nerve injury: a delivery system for therapeutic agents Ann Neurol 1998 43: 205–211

    Article  CAS  Google Scholar 

  24. Guo Z et al. Efficient and sustained transgene expression in mature rat oligodendrocytes in primary culture J Neurosci Res 1996 43: 32–41

    Article  CAS  Google Scholar 

  25. Jenkins HG, Ikeda H . Tumor necrosis factor causes an increase in axonal transport of protein and demylination in the mouse optic nerve J Neurol Sci 1992 108: 99–104

    Article  CAS  Google Scholar 

  26. Zajicek JP, Wing M, Scolding NJ, Compston DAS . Interactions between oligodendrocytes and microglia: a major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing Brain 1992 115: 1611–1631

    Article  Google Scholar 

  27. Monastra G, Cross AH, Bruni A, Raine CS . Phosphatidylserine, a putative inhibitor of tumor necrosis factor, prevents autoimmune demyelination Neurology 1993 43: 153–163

    Article  CAS  Google Scholar 

  28. Liu JL et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination Nature Med 1998 4: 78–83

    Article  CAS  Google Scholar 

  29. Bansal R, Pfeiffer SE . FGF-2 converts mature oligodendrocytes to a novel phenotype J Neurosci Res 1997 50: 215–228

    Article  CAS  Google Scholar 

  30. Muir DA, Compston DAS . Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes J Neurosci Res 1996 44: 1–11

    Article  CAS  Google Scholar 

  31. Yao D-L, Liu X, Hudson LD, Webster HD . Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis Proc Natl Acad Sci USA 1995 92: 6190–6194

    Article  CAS  Google Scholar 

  32. Fressinaud C, Vallat JM, Pouplard-Barthelaix A . Platelet-derived growth factor partly prevents chemically induced oligodendrocyte death and improves myelin-like membranes repair in vitro Glia 1996 16: 40–50

    Article  CAS  Google Scholar 

  33. Woodruff RH, Franklin RJM . Growth factors and remyelination in the CNS Histol Histopath 1997 12: 459–466

    CAS  Google Scholar 

  34. Butt AM, Ransom BR . Visualisation of oligodendrocytes and astrocytes in the intact rat optic nerve by intracellular injection of lucifer yellow and horseradish peroxidase Glia 1989 2: 470–475

    Article  CAS  Google Scholar 

  35. Caillaud C et al. Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells Eur J Neurosci 1993 5: 1287–1291

    Article  CAS  Google Scholar 

  36. Byrnes AP, Wood MJ, Charlton HM . Role of T cells in inflammation caused by adenovirus vectors in the brain Gene Therapy 1996 3: 644–651

    CAS  Google Scholar 

  37. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy Proc Natl Acad Sci USA 1994 91: 4407–4411

    Article  CAS  Google Scholar 

  38. Gilgenkrantz H et al. Transient ecpression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response Hum Gene Ther 1995 6: 1265–1274

    Article  CAS  Google Scholar 

  39. Kay MA et al. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA41g administration Nat Genet 1998 11: 191–197

    Article  Google Scholar 

  40. Boviatsis EJ et al. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors Hum Gene Ther 1994 5: 183–191

    Article  CAS  Google Scholar 

  41. Kochanek S et al. A new adenoviral vector: replacement of all viral coding sequences with 28kb of DNA independently expressing both full-length dystrophin and beta-galactosidase Proc Natl Acad Sci USA 1996 93: 5731–5736

    Article  CAS  Google Scholar 

  42. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain Nat Genet 1994 8: 148–154

    Article  CAS  Google Scholar 

  43. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 1996 272: 263–267

    Article  CAS  Google Scholar 

  44. Stratford-Perricaudet LD et al. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector Hum Gene Ther 1990 1: 241–256

    Article  CAS  Google Scholar 

  45. Lisovoski F et al. Phenotypic alteration of astrocytes induced by ciliary neurotrophic factor in the intact adult brain, as revealed by adenovirus-mediated gene transfer J Neurosci 1997 17: 7228–7236

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Professor A Kahn, Professor WF Blakemore and Dr MT O’Leary for their support and helpful discussion and L Castelnau-Ptakhine, M Peacock and C Ready for excellent technical help. This work was supported by the Wellcome Trust, Association Française contre les Myopathies and a Research Travel Award from the British Neuropathological Society. RJMF is a Wellcome Research Career Development Fellow.

Author information

Authors and Affiliations

  1. Department of Clinical Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK

    R J M Franklin & M M Quick

  2. INSERM 129, Institut Cochin de Génétique Moléculaire, CHU Cochin-Port-Royal, Paris, France

    G Haase

Authors
  1. R J M Franklin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M M Quick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Haase
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franklin, R., Quick, M. & Haase, G. Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequences. Gene Ther 6, 1360–1367 (1999). https://doi.org/10.1038/sj.gt.3300971

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300971

Keywords

This article is cited by

Search

Advanced search

Quick links